The wait is over!

We are now accepting samples for sequencing on illumina's NovaSeq X Plus platform.

NovaSeqTM X Plus has just been installed and went live. Novogene is the 1st NGS service provider to publish our validation data on the latest illumina platform. Click here to find out more about how the data compares with sequencing data on NovaSeq 6000.
What do we accept now?
  • Lane sequencing of premade library (375Gb/lane)
  • Human WGS (Minimal 1 NovaSeq X Plus lane)
  • Plant and Animal WGS (Minimal 1 NovaSeq X Plus lane)
Novogene is the first NGS service provider to publish our validation data on the latest Illumina platform!

Check out the validation run with the PhiX library and human whole genome sequencing here. With a maximum data output of 465Gb/lane and an average Q30 >95%, Novogene's NovaSeq X Plus data showcases exceptional performance!

The NovaSeq X Plus platform offers outstanding sequencing power not only for whole genome sequencing but also for whole exome sequencing and transcriptome sequencing. In addition to the previous release of human whole genome sequencing tests on the NovaSeq X Plus, we now have data available for more library types here.
Planning your next sequencing project? Have needs beyond what we can accept? Contact us to have a free non-obligatory project consultation on how you may stretch your budget!
By registering on this page, I consent and agree for Novogene to contact me, assist with my request, and store my information per our privacy policy. You can change your email preferences at any time.

Sequencing read length matters for your genomic research? Do you prefer long-read sequencing for your project?

We are running a registration of interest for PacBio Revio platform. Contact us for more information.

About Novogene
Novogene is a pioneer in applying cutting-edge molecular biology technology and high-performance computing to research in the fields of life science and human health. Our vision is to continue as a global leader in the delivery of genomics services and solutions. With one of the largest sequencing capacities in the world, we utilise our deep scientific knowledge, first-class customer service and unsurpassed data quality to help clients realise their research goals in the rapidly evolving world of genomics. Novogene is committed to become your trusted genomics partner.
NovogeneAIT Genomics is a joint venture between Novogene and AIT Biotech focusing in Asia Pacific, Middle East, and Africa (AMEA) region. The AMEA regional headquarters of Novogene is in Singapore, overseeing a dynamic and diverse region with a presence in Singapore, Japan, Hong Kong SAR, Taiwan, Australia, India, the Middle East and across the region through our network of local partners.
© 2023 Novogene Co., Ltd. All Rights Reserved
NovogeneAIT Genomics Pte. Ltd.
(Regional Office for Asia Pacific, Middle-East & Africa)
11 Biopolis Way, #10-11 Helios,
Singapore 138667  
Novogene Japan K.K.
Kayabacho-Nagaoka BLDG3-7F, 2-7-10,
Nihonbashi-Kayabacho, Chuo City,
Tokyo,103-0025 Japan
Novogene (HK) Company Limited
Unit 1307, Everglory Centre,
1B Kimberly Street, 
Tsim Sha Tsui, Hong Kong